Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.
about
Human polyomavirus reactivation: disease pathogenesis and treatment approachesCMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytesProgressive multifocal leukoencephalopathy: current treatment options and future perspectivesProgressive multifocal leukoencephalopathy: clinical and molecular aspectsImproved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapyProgressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.Clinical Trials in Neurovirology: Successes, Challenges, and PitfallsImmune reconstitution inflammatory syndrome in a patient with progressive multifocal leukoencephalopathy.Progressive multifocal leukoencephalopathy in HIV-1 infection.Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.Update on opportunistic infections in the era of effective antiretroviral therapyRearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rateToxicities of immunosuppressive treatment of autoimmune neurologic diseases.Hexadecyloxypropyl-cidofovir (CMX001) suppresses JC virus replication in human fetal brain SVG cell cultures.JC Virus Leuko-Encephalopathy in Reduced Intensity Conditioning Cord Blood Transplant Recipient with a Review of the Literature.Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy.Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment optionDeterminants of survival in progressive multifocal leukoencephalopathyAn animal model for progressive multifocal leukoencephalopathyRituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritisCNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.Immune surveillance and response to JC virus infection and PML.Treating multiple sclerosis with monoclonal antibodies: a 2010 update.HIV-associated neurological disorders: a guide to pharmacotherapy.Update on progressive multifocal leukoencephalopathy.Evaluation of progressive multifocal leukoencephalopathy treatments in a Spanish cohort of HIV-infected patients: do protease inhibitors improve survival regardless of central nervous system penetration-effectiveness (CPE) score?The human JC polyomavirus (JCPyV): virological background and clinical implications.Progressive multifocal leukoencephalopathy therapyOpportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review.45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches.Progressive multifocal leukoencephalopathy after liver transplantation can have favorable or unfavorable outcome.Activities of different classes of acyclic nucleoside phosphonates against BK virus in primary human renal cells.Identification and characterization of mefloquine efficacy against JC virus in vitro.Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a man with AIDS.PML therapy: "It's Déjà vu all over again".Progressive multifocal leukoencephalopathy with gastrointestinal disease in a pediatric kidney transplant recipient.Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression
P2860
Q21285083-D0E54E52-236C-4549-9658-5A208F3A8C00Q24599841-CA95A707-D525-42A1-A49D-733D06A498A3Q26776236-60C4339F-1E64-40D2-85AF-7C6CCE943E2AQ26858968-42C1EE4F-00FD-406F-A64B-587407CFE270Q28478894-F26990FD-EFC7-487C-AFF7-CDEAC0972AECQ30235523-415643D0-97FC-444F-9B4D-6B061D3A215EQ30245002-0497358D-C491-40CE-9487-0CD363F7182EQ30250271-EED7E2B8-5DCC-474B-9686-BF2067D59F82Q30969485-A325BD66-CDF7-4980-9088-78850E20DE8FQ33506561-C585D0C5-4D0B-412F-913C-EADF0B03F6CEQ33893285-B05DE4AD-B952-4AB5-8C70-4CF3A67E8425Q34085853-C4811810-697E-44DA-86FF-2AB07FB2ACE2Q34178250-077EBCC7-900D-4916-B08C-5BC1F4E1A0B6Q34257903-BA7F9EC6-EF79-4E63-BCA9-3EC3732BF844Q34290158-29EA48EF-04F8-46B8-B5C2-36C28B0B15B8Q34343528-18634804-CC2B-446B-8478-6447C4A20F06Q34802752-610D55CC-70D7-4D3C-ACF9-E9C6CFA263C7Q34816447-F44B4B56-0C73-4035-BF41-3630533F6035Q35012056-CD32628E-F6DD-469C-96D9-7D4488A1E41DQ35145409-FE21507F-A05D-41A6-8D01-DDD259F871BEQ36190565-E135A58A-A102-49D9-BC2C-DD04DF84577CQ37041199-BBE80267-1CE3-4ACB-925B-3D2BB077A75AQ37157144-2C116108-EC80-4663-BB10-1C2AF93B4F9DQ37678580-E55CA0F1-0202-47B5-B950-E358AFD16BC7Q37737305-1DF55FBE-9EF0-4A97-9402-691E09670365Q37971469-6DE789CD-A24A-40A4-AE0F-C9C198BCBCA3Q38044681-28E7B1A3-D6AD-4DEB-8BED-43DAC7733093Q38065339-6389E088-5DE0-4867-9C3C-ED49F29357F8Q38115572-FEF1C442-536C-4B3D-8384-C16943D3EDFFQ38250227-8260EB1C-492C-43D6-BB41-AF43FD924799Q38414352-5C4369BA-EFFD-4D0C-975C-EFFD7723CBA1Q38801394-9DA9CB05-4938-40E9-A7C0-87451A5B65C3Q38844198-5283E4F6-E99F-42AC-8947-F52B86C4E824Q39587782-B5014D52-1470-46CB-BCDA-AEE89E931E03Q39877627-86EDCC6A-BEFA-47B0-8FA8-F4AB116FC6C4Q40039520-11DED32A-7030-47AD-BD40-6C56B15CE6A8Q41964449-CF5A051B-3E37-49CA-BEAE-11F405DA4961Q42279234-A77E5BDF-3443-424A-8776-6D4C751179B9Q42280105-34CD3AB7-E311-4B0A-8174-F2F69F8FECBBQ42410099-77931001-2B79-4CF8-B0E3-1E37D9AFA395
P2860
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Cidofovir in addition to antir ...... pathy: a multicohort analysis.
@en
Cidofovir in addition to antir ...... pathy: a multicohort analysis.
@nl
type
label
Cidofovir in addition to antir ...... pathy: a multicohort analysis.
@en
Cidofovir in addition to antir ...... pathy: a multicohort analysis.
@nl
prefLabel
Cidofovir in addition to antir ...... pathy: a multicohort analysis.
@en
Cidofovir in addition to antir ...... pathy: a multicohort analysis.
@nl
P2093
P50
P1433
P1476
Cidofovir in addition to antir ...... pathy: a multicohort analysis.
@en
P2093
Christina M Marra
Gesida 9/99, IRINA, ACTG 363 Study Groups
Jacques Gasnault
Juan Berenguer
Paola Cinque
Patrizio Pezzotti
Pilar Miralles
Yassine Taoufik
P304
P356
10.1097/QAD.0B013E32830A5043
P407
P577
2008-09-01T00:00:00Z